SEC Comment Letter for BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149) (BIVI) — Oct 3, 2019
BIOVIE INC. (BIVI, BIVIW) (CIK 0001580149)
Date: Oct. 3, 2019 · CIK: 0001580149 · Accession: 0000000000-19-014271
AI Filing Summary & Sentiment
File numbers found in text: 333-231136
Letter
October 3, 2019 Terren Peizer Chairman and Chief Executive Officer BioVie Inc. 2120 Colorado Avenue #230 Santa Monica, CA 90404 Re:BioVie Inc. Amendment No. 4 to Registration Statement on Form S-1 Filed October 2, 2019 File No. 333-231136 Dear Mr. Peizer: We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to the comment, we may have additional comments. Amendment No. 4 to Registration Statement on Form S-1 filed on October 2, 2019 Description of Capital Stock Warrants to be Issued in this Offering Exchange Listing, page 52 1.We note your disclosure that no assurance can be given that you will be successful in listing the warrants on Nasdaq. Please clarify here and on the cover page whether the offering is contingent on your securing listing approval for the warrants.
FirstName LastNameTerren Peizer Comapany NameBioVie Inc. October 3, 2019 Page 2 FirstName LastName Terren Peizer BioVie Inc. October 3, 2019 Page 2 Please contact Christine Westbrook at 202-551-5019 or Mary Beth Breslin at 202-551- 3625 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Mitchell S. Nussbaum, Esq.
Show Raw Text
October 3, 2019
Terren Peizer
Chairman and Chief Executive Officer
BioVie Inc.
2120 Colorado Avenue #230
Santa Monica, CA 90404
Re:BioVie Inc.
Amendment No. 4 to Registration Statement on Form S-1
Filed October 2, 2019
File No. 333-231136
Dear Mr. Peizer:
We have reviewed your amended registration statement and have the following
comment. In our comment, we may ask you to provide us with information so we may better
understand your disclosure.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to the comment, we may have additional comments.
Amendment No. 4 to Registration Statement on Form S-1 filed on October 2, 2019
Description of Capital Stock
Warrants to be Issued in this Offering
Exchange Listing, page 52
1.We note your disclosure that no assurance can be given that you will be successful in
listing the warrants on Nasdaq. Please clarify here and on the cover page whether the
offering is contingent on your securing listing approval for the warrants.
FirstName LastNameTerren Peizer
Comapany NameBioVie Inc.
October 3, 2019 Page 2
FirstName LastName
Terren Peizer
BioVie Inc.
October 3, 2019
Page 2
Please contact Christine Westbrook at 202-551-5019 or Mary Beth Breslin at 202-551-
3625 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Mitchell S. Nussbaum, Esq.